Hummingbird Bio raises $19M in Series B round

Singapore |  News | 0 Comment | 06 Dec, 2019

Hummingbird Bioscience, an innovative biotherapeutics company located in Singapore and US, has announced that it has raised $19 million in a Series B financing round. The fi...Read more

Singapore approves new early breast cancer drug

Singapore |  News | 0 Comment | 03 Dec, 2019

A new breast cancer drug shown to significantly reduce the risk of cancer recurrence has received approval in Singapore – at least six months ahead of its expected...Read more

NOVI Health collaborates with Great Eastern

Singapore |  News | 0 Comment | 03 Dec, 2019

NOVI Health (NOVI), an innovative and rapidly growing Singapore-based medical and digital health provider, with a focus on preventing and reversing chronic lifestyle-related diseases, has c...Read more

Singapore announces its first brain bank

Singapore |  News | 0 Comment | 02 Dec, 2019

Nanyang Technological University, Singapore’s (NTU Singapore) Lee Kong Chian School of Medicine (LKCMedicine), in partnership with National Healthcare Group (NHG) and National Neurosc...Read more

NSG BioLabs launches co-working space for startups

Singapore |  News | 0 Comment | 29 Nov, 2019

NSG BioLabs, a Singapore-based incubator founded to provide a conducive R&D environment to life sciences companies, had its official launch recently.  The co-working laboratory and...Read more

Lucence raises $20M to advance liquid biopsy

Singapore |  News | 0 Comment | 28 Nov, 2019

Lucence, a Singapore based genomic medicine company that invents blood-based tests for cancer screening and treatment selection, has announced the close of $20 million in Series A funding. ...Read more

NUS team creates new material for flexible soft robots

Singapore |  News | 0 Comment | 27 Nov, 2019

Origami robots are state-of-the-art soft and flexible robots that are being tested for use in various applications including drug delivery in human bodies, search and rescue missions in dis...Read more

New Breakthrough Treatment for Patients with ALK-Positive Lung Cancer

Singapore |  News | 0 Comment | 26 Nov, 2019

Pfizer on 25th Nov 2019, announced that a new breakthrough therapy, LORVIQUA has been approved by Health Sciences Authority (HSA) for patients with anaplastic lymphoma kinase (ALK)-positive...Read more

Pfizer Unveils Positive Results for VIZIMPRO® as first-line monotherapy in NSCLC patients

Singapore |  News | 0 Comment | 26 Nov, 2019

Pfizer Inc. on 25th Nov 2019, announced the efficacy and tolerability results from the subgroup analysis of Asian patients enrolled in the  ARCHER 1050, a randomized, multicenter, mult...Read more

Merck presented Data on Tepotinib for NSCLC at ESMO Asia 2019

Singapore |  News | 0 Comment | 25 Nov, 2019

Merck, a leading science and technology company, on 25 Nov 2019, announced the presentation of multiple abstracts on tepotinib* at the European Society for Medical Oncology (ESMO) Asia Cong...Read more

5th ESMO Asia Congress highlights Asia’s increasing Cancer Burden

Singapore |  News | 0 Comment | 25 Nov, 2019

The ESMO Asia Congress 2019 came to a close on 24th Nov 2019, after three days of thought-provoking lectures aimed at shaping the future of cancer care and keeping the regional on...Read more

Flu vaccination lessen the preventable burden of flu in diabetics

Singapore |  News | 0 Comment | 25 Nov, 2019

A team of researchers at Singapore on 22 Nov 2019 revealed the need for improved flu protection amongst those living with diabetes. In vulnerable populations such as people living with diab...Read more

Singapore to establish Smart Digital and Multiplex Path lab

Singapore |  News | 0 Comment | 26 Nov, 2019

A!maginostic (A!), an A*STAR spin-off that specialises in computational digital pathology, and A*STAR’s Institute of Molecular and Cell Biology (IMCB) have la...Read more

ESMO Asia Congress 2019: Explores Advances in cancer prevention, treatment and care

Singapore |  News | 0 Comment | 22 Nov, 2019

The ESMO Asia Congress returned for its fifth edition at the Suntec Singapore Convention & Exhibition Centre, on 22nd to 24th Nov 2019, bringing together over 3,500 medical professional...Read more

Combination of Immunotherapy and VEGF Inhibitor Improves Survival in HCC

Singapore |  News | 0 Comment | 22 Nov, 2019

Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves overall survival and progression-free survival in patients with unresecta...Read more

Trastuzumab Biosimilar HLX02 Met Primary Endpoint in Breast Cancer

Singapore |  News | 0 Comment | 22 Nov, 2019

The trastuzumab biosimilar HLX02 achieved similar overall response rate to reference trastuzumab in women with human epidermal growth factor receptor 2-positive (HER2+) recurrent or previou...Read more

Singapore makes progress in war against diabetes

Singapore |  News | 0 Comment | 22 Nov, 2019

The Ministry of Health (MOH) in Singapore has released a summary report highlighting the key initiatives and progress made on the War of Diabetes (WoD) over the past three years in addressi...Read more

Medtech startup Eko.ai clinches Startup SG's SLINGSHOT 2019 top prize

Singapore |  News | 0 Comment | 21 Nov, 2019

Eko.ai was awarded the Startup SG grand prize of S$250,000 Startup SG grant at SLINGSHOT 2019 powered by Startup SG, organised by Enterprise Singapore. The competition, held in Singapore on...Read more